L Sekar
Impact in
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology
- HIV/AIDS drug development and treatment
Papers in
-
- Tuberculosis Research and Epidemiology 9
- HIV/AIDS drug development and treatment 4
-
- Pneumocystis jirovecii pneumonia detection and treatment 7
- Co-authors
- Soumya Swaminathan (8 shared papers)Geetha Ramachandran (6 shared papers)A. K. Hemanth Kumar (4 shared papers)Chandrasekaran Padmapriyadarsini (6 shared papers)N. Ravichandran (3 shared papers)S. Rajasekaran (2 shared papers)Prem Venkatesan (2 shared papers)Prema Gurumurthy (2 shared papers)
- Journals
- Clinical Infectious Diseases (2 papers)The International Journal of Tuberculosis and Lung Disease (2 papers)The Indian Journal of Medical Research (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)International Journal of Applied Pharmaceutics (1 paper)
- Partner nations
- IndiaUnited States
In The Last Decade
L Sekar
12 papers receiving 373 citations
Peers
Comparison fields: 5 of 56
- Infectious Diseases 318
- Applied Microbiology and Biotechnology 17
- Epidemiology 203
- Pharmacology 76
- Geriatrics and Gerontology 17
Countries citing papers authored by L Sekar
This map shows the geographic impact of L Sekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Sekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Sekar more than expected).
Fields of papers citing papers by L Sekar
This network shows the impact of papers produced by L Sekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Sekar. The network helps show where L Sekar may publish in the future.
Co-authors
The 25 scholars most cited alongside L Sekar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 118 | |
| 2 | 2004 | 82 | |
| 3 | 2013 | 68 | |
| 4 | Private pharmacies in tuberculosis control--a neglected link. | 2002 | 39 |
| 5 | 2014 | 23 | |
| 6 | 2014 | 18 | |
| 7 | Effectiveness of symptom screening and incidence of tuberculosis among adults and children living with HIV infection in India. | 2018 | 9 |
| 8 | 2020 | 6 | |
| 9 | 2017 | 5 | |
| 10 | 2015 | 4 | |
| 11 | 2024 | 4 | |
| 12 | 2021 | 1 |
About L Sekar
L Sekar is a scholar working on Infectious Diseases, Epidemiology, Pharmacology, Pediatrics, Perinatology and Child Health and Surgery, having authored 12 papers that have together received 377 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (9 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers), HIV/AIDS drug development and treatment (4 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper), Pharmacological Effects and Toxicity Studies (1 paper), Maternal and Perinatal Health Interventions (1 paper) and HIV-related health complications and treatments (1 paper). The work is most often cited by research in Infectious Diseases (318 citations), Applied Microbiology and Biotechnology (17 citations), Epidemiology (203 citations), Pharmacology (76 citations) and Geriatrics and Gerontology (17 citations). L Sekar has collaborated with scholars based in India and United States. Frequent co-authors include Soumya Swaminathan, Geetha Ramachandran, A. K. Hemanth Kumar, Chandrasekaran Padmapriyadarsini, N. Ravichandran, S. Rajasekaran, Prem Venkatesan, Prema Gurumurthy, S Bhagavathy and Fauzie Rahman. Their work appears in journals such as Clinical Infectious Diseases, The International Journal of Tuberculosis and Lung Disease, The Indian Journal of Medical Research, Antimicrobial Agents and Chemotherapy and International Journal of Applied Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.